1. Home
  2. PCLA vs ATYR Comparison

PCLA vs ATYR Comparison

Compare PCLA & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$5.55

Market Cap

47.2M

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.48

Market Cap

51.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCLA
ATYR
Founded
2008
2005
Country
Japan
United States
Employees
55
58
Industry
Building Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.2M
51.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PCLA
ATYR
Price
$5.55
$0.48
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$3.67
AVG Volume (30 Days)
447.6K
1.9M
Earning Date
02-13-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.40
52 Week High
$14.10
$7.29

Technical Indicators

Market Signals
Indicator
PCLA
ATYR
Relative Strength Index (RSI) 55.21 41.24
Support Level $1.89 $0.44
Resistance Level $8.00 $0.86
Average True Range (ATR) 0.60 0.05
MACD 0.06 -0.01
Stochastic Oscillator 96.71 8.51

Price Performance

Historical Comparison
PCLA
ATYR

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: